According to Immix Biopharma's latest financial reports the company's current earnings (TTM) are -S$25.77 M. In 2023 the company made an earning of -S$20.49 M a decrease over its 2022 earnings that were of -S$10.71 M.The earnings displayed on this page is the company's Pretax Income.